HLIB Research maintains Buy on Tambun Indah, raises target price to RM2.60
Page 1 of 1
HLIB Research maintains Buy on Tambun Indah, raises target price to RM2.60
HLIB Research maintains Buy on Tambun Indah, raises target price to RM2.60 |
Business & Markets 2014 |
Written by theedgemalaysia.com |
Wednesday, 20 August 2014 08:40 KUALA LUMPUR (Aug 20): Hong Leong IB Research (HLIB) has maintained its Buy rating on Tambun Indah Land Bhd (TILB) with a higher target price of RM2.60 (from RM2.55) and said teh company’s 1H results were slightly ahead of house and street estimates (52% / 54%), due to a combination of robust topline growth and lower marketing expenses in 1H (up 49% y-o-y and down 18% y-o-y). As expected, no dividends were declared in 1H14, HLIB said in a report Wednesday. HLIB said it was encouraged by Tambun’s ability to maintain strong sales volume without the need to resort to cutting selling prices, which it said re-affirmed the research house’s positive view on the vibrant property scene on Penang mainland. “Having raised our FY14-15E forecast, we also slightly increase our target price from RM2.55 to RM2.60 (based on unchanged 10% discount to RNAV), which values TILB at 8.4x FY15E P/E, vs. 10-18x for mid/large cap property developers. “Maintain Buy,” it said. |
Cals- Administrator
- Posts : 25277 Credits : 57721 Reputation : 1766
Join date : 2011-09-08
Location : global
Comments : “My plan of trading was sound enough and won oftener that it lost. If I had stuck to it Iâ€d have been right perhaps as often as seven out of ten times.â€
Stock Exposure : Technical Analysis / Fundamental Analysis / Mental Analysis
Similar topics
» RHB Research maintains Buy on Tambun Indah, raises fair value to RM3
» JF Apex Research ups target price for Tambun Indah to RM1.81
» HLIB maintains Buy on Pharmaniaga, raises target price
» HLIB Research upgrades ViTrox to Buy, raises target price to RM3.17
» HLIB Research upgrades Sunway to Buy, raises target price to RM3.65
» JF Apex Research ups target price for Tambun Indah to RM1.81
» HLIB maintains Buy on Pharmaniaga, raises target price
» HLIB Research upgrades ViTrox to Buy, raises target price to RM3.17
» HLIB Research upgrades Sunway to Buy, raises target price to RM3.65
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum